ÇѸ²´ëÇб³¼º½Éº´¿ø

¾È¼ö°æ ±³¼ö

1577-5587 ahnsookyung@hallym.or.kr
  • Àü¹®¼¾ÅÍ ¾Ï¼¾ÅÍ
  • Áø·á°ú ¿Ü°ú

Àü¹®Áø·áºÐ¾ß

¡¼À¯¹æ°©»ó¼±¼¾ÅÍ¡½À¯¹æ¾Ï, °©»ó¼±¾Ï, ¸¾¸ðÅè ¼ö¼ú, ´ÙºóÄ¡ ·Îº¿¼ö¼ú, À¯¹æ ¹× °©»ó¼± °ËÁø ¹× ¾ç¼º Á¾¾ç

ÀüÈ­ ¿¹¾à 1577-5587
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-05-20 ~ 2024-05-25)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿¬¼öÁß
¿ÀÈÄ
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

1997.03 ~ 2003.02Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇкΠÁ¹¾÷

Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¼®»ç Á¹¾÷

Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ¹Ú»ç Á¹¾÷

°æ·Â

°æ·Â

2009.03 ~ 2010.02¼­¿ï´ëÇб³º´¿ø À¯¹æ³»ºÐºñºÐ°ú ÀüÀÓÀÇ

¼­¿ï´ëÇб³º´¿ø ¿Ü°ú À¯¹æ³»ºÐºñºÐ°ú Áø·á±³¼ö

Dana-Farber Cancer Institute Breast Oncology Program ¿¬¼ö

ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¿Ü°ú Á¶±³¼ö

ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø ¿Ü°ú ºÎ±³¼ö(ÇöÀç)

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇÑ¿Ü°úÇÐȸ Æò»ýȸ¿ø

Çѱ¹À¯¹æ¾ÏÇÐȸ Æò»ýȸ¿ø

´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ Æò»ýȸ¿ø

´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ Á¤È¸¿ø

³í¹®

¡Ý ±¹Á¦ÇÐȸÁö ¹ßÇ¥³í¹®
1. Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome; Journal of Cancer 2020

2. Global Trends in Immunotherapy Research on Breast Cancer Over the Past 10 Years; Journal of Oncology 2020

3. Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy; EJSO 2018.1

4. Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery ;Cancer Res Treat 2017


¡Ý Àú¼­/Àú¼ú
1. Çѱ¹ÀÎÀÇ °Ç°­°ËÁø : À¯¹æ¾Ï°ËÁø °øÀú °í·ÁÀÇÇÐ 2013

2. Biomarkers in Disease : Methods, Discoveries and Applications. Biomarkers in Cancer : Serum TPS as biomarker °øÀú Springer 2015

°Ç°­Á¤º¸ µ¿¿µ»ó